SIMULTANEOUS INHIBITION OF PROTEIN KINASE CK2 AND THE PROTEASOME INCREASES MULTIPLE MYELOMA CELL APOPTOSIS AND AFFECTS NF-KB AND STAT 3 SIGNALING PATHWAYS